DCAI

CAS No. 299165-92-7

DCAI( —— )

Catalog No. M27763 CAS No. 299165-92-7

DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 188 In Stock
5MG 227 In Stock
10MG 318 In Stock
25MG 535 In Stock
50MG 736 In Stock
100MG 1042 In Stock
200MG Get Quote In Stock
500MG 2093 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DCAI
  • Note
    Research use only, not for human use.
  • Brief Description
    DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
  • Description
    DCAI is an inhibitor of nucleotide exchange and nucleotide release acting by binding to the pocket adjacent to the Ras-SOS interface.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    mTOR (FKBP12)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    299165-92-7
  • Formula Weight
    243.13
  • Molecular Formula
    C11H12Cl2N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1[nH]c2cc(Cl)cc(Cl)c2c1CCN
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Maria Raffaella Martina, et al. The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands. J Med Chem. 2013 Feb 14;56(3):1041-51.
molnova catalog
related products
  • Raddeanoside 20

    Raddeanoside 20 can slightly suppress the superoxide generation induced by N-formyl-methionyl-leucyl-phenylalanine (fMLP) in a concentration dependent manner.

  • Auranamide

    Auranamide

  • Multinoside A

    Multinoside A (compound 6) is an antioxidant with DPPH free radical scavenging activity (IC50=54.3 μg/mL). Multinoside A can also downregulate COX-2 expression (IC50=9.6 μg/mL) and inhibit NO production (IC50=43.9 μg/mL).